A detailed history of Virtu Financial LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Virtu Financial LLC holds 6,433 shares of CYTK stock, worth $267,355. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,433
Holding current value
$267,355
% of portfolio
0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$46.36 - $58.62 $298,233 - $377,102
6,433 New
6,433 $303,000
Q4 2023

Feb 26, 2024

BUY
$26.88 - $83.49 $1.26 Million - $3.9 Million
46,768 New
46,768 $3.91 Million
Q4 2018

Jan 16, 2019

SELL
$5.91 - $9.29 $66,611 - $104,707
-11,271 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$6.4 - $9.85 $72,134 - $111,019
11,271 New
11,271 $111,000
Q1 2018

May 14, 2018

SELL
$7.2 - $10.05 $98,784 - $137,886
-13,720 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$7.25 - $15.65 $99,470 - $214,718
13,720
13,720 $112,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $3.91B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.